Skip to content

New results from the MELODY study highlight the variations in care experienced by transplant patients at different hospitals

New results from the MELODY study highlight the variations in care experienced by transplant patients at different hospitals 06 March 2024 Preliminary findings on the approaches taken to long-term immunosuppression in kidney transplant patients enrolled in the MELODY study presented today at the British Transplant Society Congress showed a concerning level of variation between different hospitals.…

Read More

Covid-19 autumn vaccine programme

Covid-19 autumn vaccine programme 13 September 2023 After the identification of a new Covid-19 variant, BA.2.86, health officials have brought forward this year’s autumn flu and Covid-19 vaccine programmes. Although BA.2.86 is not classified as a variant of concern, the UK Health Security Agency (UKHSA) have recommended speeding up the autumn vaccine programme as a…

Read More

Supporting the kidney disease community: new results from PROTECT-V

Supporting the kidney disease community: new results from PROTECT-V 19 June 2023 Results from the PROTECT-V study presented at the European Renal Association in Milan on 16 June 2023 showed the study treatment, nasal niclosamide, does not offer protection against Covid-19 infection in at-risk kidney patients. Although these results are disappointing, there are many positive…

Read More

Understanding the impact of the Covid-19 pandemic on kidney patient care

Understanding the impact of the Covid-19 pandemic on kidney patient care 25 May 2023 GP Dr Stuart Stewart has been awarded a Kidney Research UK grant of £250,000. The problem The Covid-19 pandemic has disrupted healthcare services in the UK, raising important questions about how well chronic kidney disease (CKD) has been detected, monitored and…

Read More

New study shows importance of Covid-19 vaccines in patients who have had a kidney transplant

New study shows importance of Covid-19 vaccines in patients who have had a kidney transplant 23 February 2023 The MELODY study, co-funded by Kidney Research UK, involved more than 28,000 immunocompromised patients across the UK, including those with solid organ transplants, patients with blood cancer and autoimmune diseases (including vasculitis and lupus). MELODY is the…

Read More

NICE U-turn gives kidney patients much needed Covid-19 treatment

NICE U-turn gives kidney patients much needed Covid-19 treatment 22 February 2023 Kidney Research UK has welcomed the revised decision by the National Institute for Health and Care Excellence (NICE) to continue access to sotrovimab (Xevudy) for the treatment of kidney disease patients who are at high risk of progressing to severe Covid-19. What is…

Read More

NICE process “not appropriate for a rapidly evolving virus”

NICE process “not appropriate for a rapidly evolving virus” 12 December 2022 We have submitted comments relating to NICE’s draft guidance on therapeutics for people with Covid-19, following the regulatory body’s draft decision to dramatically reduce the number of available treatments. We highlighted that the relevant evidence failed to consider the impact on high-risk patients…

Read More

Supporting patients for fair access to anti-virals for Covid-19

Supporting patients for fair access to anti-virals for Covid-19 16 November 2022 The National Institute for Health and Care Excellence (NICE) has today published draft recommendations to drastically reduce the number of anti-viral treatment options available for people with Covid-19. With large numbers of people on immunosuppressants or with poor kidney function left exposed by…

Read More

Making vaccinations work better for patients on dialysis

Making vaccinations work better for patients on dialysis 20 July 2022 Professor Alan Salama and his colleagues at University College London are building on their previous finding that the immune systems of dialysis patients don’t work as well as they should. We are thrilled to be able to support his work on making vaccinations work…

Read More
Scroll To Top